The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Drop in credit score after cancer diagnosis linked to increased mortality

2.

Acupuncture may alleviate nocturia in men treated for prostate cancer

3.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

4.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

5.

Where Did This Very Painful Gluteal Mass Come From?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot